
BioPharma Credit Plc
(OTC) BOPCF
BioPharma Credit Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$264.69M
Net Income (TTM)
$252.07M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.05
Beta (Volatility)
0.06 (Low)
Dividend
$0.05
Beta (Volatility)
0.06 (Low)
Price
$0.94
Volume
678
Open
$0.99
Price
$0.94
Volume
678
Open
$0.99
Previous Close
$0.94
Daily Range
$0.94 - $0.99
52-Week Range
$0.81 - $1.02
Estimated Earnings Date
Mar 23, 2026
Dividend
$0.05
Beta (Volatility)
0.06 (Low)
Price
$0.94
Volume
678
Open
$0.99
Previous Close
$0.94
Daily Range
$0.94 - $0.99
52-Week Range
$0.81 - $1.02
Estimated Earnings Date
Mar 23, 2026
BOPCF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioPharma Credit Plc
BOPCF Financials
Key Financial Metrics (TTM)
Gross Margin
93.51%
Operating Margin
92.51%
Net Income Margin
92.62%
Return on Equity
11.29%
Return on Capital
11.28%
Return on Assets
11.12%
Earnings Yield
N/A
Dividend Yield
5.45%
Payout Ratio
84.98%
Stock Overview
Market Cap
N/A
Shares Outstanding
0
Volume
678
Avg. Volume
48.36K
Financials (TTM)
Gross Profit
$238.96M
Operating Income
$252.03M
EBITDA
$201.70M
Operating Cash Flow
$203.01M
Capital Expenditure
$0.00
Free Cash Flow
$203.01M
Cash & ST Invst.
$12.59M
Total Debt
$0.00
BioPharma Credit Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$63.08M
+10.2%
Gross Profit
$47.36M
-17.2%
Gross Margin
75.07%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
0
N/A
Net Income
$57.10M
+52.2%
EBITDA
$57.10M
+52.2%
Quarterly Fundamentals
Total Cash
$12.59M
-90.7%
Total Debt
$0.00
N/A
Accounts Receivable
$53.60M
+165.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
11.12%
N/A
Return on Invested Capital
11.24%
N/A
Free Cash Flow
$57.34M
-38.2%
Operating Cash Flow
$57.34M
-38.2%